NASDAQ: SNES Second Quarter Fiscal Year 2021 8 ContraPest® is registered federally as a General Use Product when used as directed. However, in some states, due to applicator expertise, it is a Restricted Use Product. Please check with your local state regulatory agency to determine restriction status. Read and follow all label instructions for target species Norway and roof rats. SENESTECH SenesTech Disclaimer Special Note Regarding Forward-Looking Statements The following information and the statements mad ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission File Number: 001-37941 SENESTECH, INC. (Exact name of registrant as specified in its charter) Delaware 20-2079805 (State or other jurisdic ...

SenesTech, Inc. (NASDAQ:SNES) Q2 2021 Earnings Conference Call August 12, 2021 5:00 PM ET Company Participants Robert Blum – Managing Partner, Lytham Partners Ken Siegel – Chief Executive Officer Nicole Williams – Chief Strategy Officer Tom Chesterman – Chief Financial Officer Conference Call Participants Operator Good day, and welcome to the SenesTech, Inc. Second Quarter Fiscal Year 2021 Financial Results. All participants will be in a listen-only mode. [Operator Instructions] After today’s presentation, ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934: | | | Name of each exchange on which | | --- | --- | --- | | Title of each class | Trading Symbol(s) | registered | | Common Stock, $0.001 par value | SNES | The NASDAQ Stock Market LLC | | | | (NASDAQ Capi ...

Senestech, Inc. (NASDAQ:SNES) Q1 2021 Earnings Conference Call May 13, 2021 5:00 PM ET Company Participants Joe Diaz - Lytham Partners Kenneth Siegel - CEO & Director Thomas Chesterman - EVP, CFO, Treasurer & Assistant Secretary Conference Call Participants Operator Good day, and welcome to the SenesTech's first quarter fiscal year 2021 financial results. [Operator Instructions]. I would now like to turn the conference over to Joe Diaz with Lytham Partners. Please go ahead. Joe Diaz Thank you, Carl, and tha ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37941 SENESTECH, INC. (Exact name of registrant as specified in its charter) | Delaware | 20-2079805 | | --- | --- | | (State or othe ...

Financial Data and Key Metrics Changes - Revenue for the year was approximately $282,000 compared to approximately $143,000 in 2019, an increase of 97% [37] - Fourth quarter revenue was $97,000, which included $24,000 of grant revenue received [37] - Net loss for the year was $8.4 million compared with a loss of $10 million in 2019 [42] Business Line Data and Key Metrics Changes - Significant progress was made in obtaining real-world data, particularly in agricultural and urban settings, demonstrating the efficacy of ContraPest [12][20] - In agricultural settings, ContraPest cut rat populations in half within three months and produced a sustained 90% decline in rat activity over 12 months [14] - In urban settings, one site showed a 94% reduction in rat activity and a 98% decline in juvenile rats over 12 months [20] Market Data and Key Metrics Changes - The company is focusing on California due to the adoption of the Ecosystem Protection Act, which limits the use of common rodenticides [49] - The company is also targeting the southeastern U.S. and looking to expand into grain storage and transport markets [51] Company Strategy and Development Direction - The company is focused on ramping adoption of ContraPest in commercial settings and enhancing its e-commerce capabilities [29][30] - A collaboration with Liphatech was announced to develop a new non-liquid formulation of ContraPest, opening new market opportunities [24] - The company aims to leverage existing systems and regional distributors to increase market penetration [52] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism for 2021, highlighting significant steps taken to position the company for future growth [31][34] - The company has a strong balance sheet with approximately $17.5 million in cash, providing visibility for driving business adoption [44] Other Important Information - Operating expenses decreased to $7.9 million in 2020 from $10 million in 2019, with sustainable operational improvements contributing to this reduction [41] - The company completed a $10 million private placement in February and a $4 million financing in March [43] Q&A Session Summary Question: What is the commercialization strategy going forward? - The focus will be on California, particularly with the Ecosystem Protection Act, and outreach to municipalities is a priority [49][50] Question: Will the company be more aggressive in marketing efforts now that it has a strong balance sheet? - Yes, the company plans to ramp up advertising and deploy cash strategically to drive sales [55][56] Question: What drove the top-line growth in 2020? - Growth was driven by a mix of direct sales and increased orders from various distributors, not solely from the online portal [57][58] Question: What is the share count after recent financings? - The pro forma share count is approximately 12.2 million [59] Question: What milestones should be looked for in 2021? - Key milestones include execution and revenue growth, along with updates on product improvements and initiatives with the EPA [60]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission File Number: 001-37941 SENESTECH, INC. (Exact name of registrant as specified in its charter) | Delaware | 20-2079805 | | --- | --- | ...

SenesTech, Inc. (NASDAQ:SNES) Q3 2020 Earnings Conference Call November 11, 2020 5:00 PM ET Company Participants Robert Blum - Lytham Partners Ken Siegel - Chief Executive Officer Tom Chesterman - Chief Financial Officer Conference Call Participants Pete Enderlin - Maz Partners Operator Good day, and welcome to the SenesTech Inc Reports Third Quarter Fiscal Year 2020 Financial Results. All participants will be in listen-only mode. [Operator Instructions] Please note, this event is being recorded. I would no ...

Financial Data and Key Metrics Changes - Revenue for Q2 2020 was $71,000, compared to $24,000 in Q2 2019 and $37,000 in Q1 2020, marking significant growth [40] - Total revenue for the first half of 2020 was $108,000, a 150% increase year-over-year from $43,000 in the first half of 2019, and a 90% sequential growth from Q1 2020 [42] - Adjusted EBITDA loss was $1.4 million for Q2 2020, an improvement from a $2.2 million loss in Q1 2020 [49] Business Line Data and Key Metrics Changes - The revenue growth is attributed to the e-commerce channel, which has shown strong results, particularly among DIY customers and smaller pest management professionals [43] - The company has implemented service fees for technical services, which is expected to grow as demand increases [41] Market Data and Key Metrics Changes - The company has added 208 new accounts through July 2020, compared to 63 new accounts added in all of 2019, indicating accelerated growth [25] - The e-commerce platform has enabled the company to tap into the direct-to-consumer market, showing significant month-to-month growth despite COVID-19 [29] Company Strategy and Development Direction - The company has refocused its sales and marketing efforts to drive demand in targeted verticals and launched an e-commerce platform for direct sales [14][29] - The repositioning of ContraPest as part of an integrated pest management strategy aims to improve its effectiveness and acceptance in the market [15][31] - The company is working on new dispensers and formulations to expand the usability of ContraPest, with plans to submit a new dispenser for EPA approval [21][34] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the challenges posed by COVID-19 but remains optimistic about the company's progress and future economic performance [7][38] - The company has implemented cost-cutting measures, reducing expenses by over $200,000 per month, and raised $4.3 million in capital to fund operations [35][51] Other Important Information - The company has secured new manufacturing space in Phoenix, which is expected to improve efficiency and reduce costs [45][46] - The California AB1788 bill has been reactivated, which could have implications for the industry, although the future remains uncertain [36][60] Q&A Session Summary Question: Expansion in San Francisco - Management is awaiting clearance from San Francisco to announce details regarding the size and implementation of the expansion [56][57] Question: Future of California's AB1788 - Management indicated that amendments to the bill may allow for exemptions, making it potentially more acceptable to the industry [60][61] Question: Headcount and Income Statement - Management clarified that any headcount increases would be for revenue-producing positions, avoiding general administrative additions [66]